SK bioscience completes Phase 2 trial for pneumococcal vaccine -
| 025900 Stock | KRW 8,480 10.00 0.12% |
About 54% of Dongwha Enterprise's investor base is interested to short. The analysis of current outlook of investing in Dongwha Enterprise CoLtd suggests that many traders are impartial regarding Dongwha Enterprise's prospects. The current market sentiment, together with Dongwha Enterprise's historical and current headlines, can help investors time the market. In addition, many technical investors use Dongwha Enterprise CoLtd stock news signals to limit their universe of possible portfolio assets.
Dongwha |
SK bioscience completes Phase 2 trial for pneumococcal vaccine
Read at news.google.com
 |
Dongwha Enterprise Fundamental Analysis
We analyze Dongwha Enterprise's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dongwha Enterprise using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dongwha Enterprise based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Dongwha Enterprise is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Dongwha Enterprise CoLtd Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dongwha Enterprise stock to make a market-neutral strategy. Peer analysis of Dongwha Enterprise could also be used in its relative valuation, which is a method of valuing Dongwha Enterprise by comparing valuation metrics with similar companies.
Peers
Dongwha Enterprise Related Equities
| 025980 | Ananti | 0.71 | ||||
| 041830 | InBody CoLtd | 0.21 | ||||
| 066970 | LF | 1.71 | ||||
| 025950 | Dongsin Engineering | 4.91 |
Complementary Tools for Dongwha Stock analysis
When running Dongwha Enterprise's price analysis, check to measure Dongwha Enterprise's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dongwha Enterprise is operating at the current time. Most of Dongwha Enterprise's value examination focuses on studying past and present price action to predict the probability of Dongwha Enterprise's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dongwha Enterprise's price. Additionally, you may evaluate how the addition of Dongwha Enterprise to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |